Ostex to cut workforce and make other savings
This article was originally published in Clinica
Ostex International has cut its workforce by 30% which, together with other cost-cutting measures, is expected to result in a 40% reduction in operating expenses in 1999. The company now believes it has sufficient cash flow for three years of operations, providing it maintains current sales performance.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.